**Introduction to Pyrazinamide Nitrate Salt** Pyrazinamide nitrate salt is a chemical compound widely used in pharmaceutical research and development, particularly in the treatment of tuberculosis (TB). As a derivative of pyrazinamide, a first-line anti-TB drug, the nitrate salt form enhances solubility and stability, making it valuable for formulation studies. Its mechanism involves disrupting mycobacterial cell metabolism, contributing to the effective eradication of *Mycobacterium tuberculosis*. Researchers also utilize pyrazinamide nitrate salt in synthesizing novel derivatives to combat drug-resistant TB strains. With its critical role in antimicrobial therapy, this compound remains a key focus in medicinal chemistry and infectious disease research, aiding advancements in global TB control efforts.
Preparation Process: To prepare Pyrazinamide nitrate salt, dissolve pyrazinamide (1.23 g, 10 mmol) in a minimal volume of warm ethanol (95%, ~20 mL). In a separate container, dissolve nitric acid (0.63 mL, 10 mmol, 65% w/w) in cold ethanol (10 mL). Slowly add the nitric acid solution to the pyrazinamide solution with stirring at 0–5°C. A white precipitate forms immediately. Stir the mixture for 1 hour, then filter under vacuum. Wash the solid with cold ethanol (2 × 5 mL) and dry it in a desiccator over silica gel for 24 hours. The yield is typically >85%. Store the product in an airtight container.
Usage Scenarios: Pyrazinamide nitrate salt is primarily used in pharmaceutical research and development, particularly in the study of antitubercular agents. It serves as a derivative of pyrazinamide, a key drug in the treatment of tuberculosis (TB), to enhance solubility or modify pharmacokinetic properties. Researchers utilize this compound to investigate its efficacy, stability, and mechanisms of action against Mycobacterium tuberculosis. It may also be employed in synthesizing novel analogs for improved therapeutic outcomes. Additionally, the nitrate salt form can be valuable in analytical chemistry for standardization and quality control of pyrazinamide-based formulations. Its applications extend to preclinical studies for evaluating drug delivery systems and combination therapies.